• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1985-2009 年欧洲经济区人群多发性硬化症发病率:监测框架。

Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.

机构信息

National Centre for Epidemiology, Carlos III Institute of Health, and Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Av Monforte de Lemos 5, Madrid 28029, Spain.

出版信息

BMC Neurol. 2013 Jun 12;13:58. doi: 10.1186/1471-2377-13-58.

DOI:10.1186/1471-2377-13-58
PMID:23758972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3686603/
Abstract

BACKGROUND

A debate surrounding multiple sclerosis epidemiology has centred on time-related incidence increases and the need of monitoring. The purpose of this study is to reassess multiple sclerosis incidence in the European Economic Area.

METHODS

We conducted a systematic review of literature from 1965 onwards and integrated elements of original research, including requested or completed data by surveys authors and specific analyses.

RESULTS

The review of 5323 documents yielded ten studies for age- and sex-specific analyses, and 21 studies for time-trend analysis of single data sets. After 1985, the incidence of multiple sclerosis ranged from 1.12 to 6.96 per 100,000 population, was higher in females, tripled with latitude, and doubled with study midpoint year. The north registered increasing trends from the 1960s and 1970s, with a historic drop in the Faroe Islands, and fairly stable data in the period 1980-2000; incidence rose in Italian and French populations in the period 1970-2000, in Evros (Greece) in the 1980s, and in the French West Indies in around 2000.

CONCLUSIONS

We conclude that the increase in multiple sclerosis incidence is only apparent, and that it is not specific to women. Monitoring of multiple sclerosis incidence might be appropriate for the European Economic Area.

摘要

背景

围绕多发性硬化症流行病学的争论集中在与时间相关的发病率增加和监测需求上。本研究旨在重新评估欧洲经济区多发性硬化症的发病率。

方法

我们对 1965 年以后的文献进行了系统回顾,并整合了原始研究的要素,包括作者要求或完成的调查数据以及特定的分析。

结果

对 5323 份文件的审查得出了 10 项年龄和性别特定分析研究,以及 21 项关于单个数据集时间趋势分析的研究。1985 年后,多发性硬化症的发病率范围为每 10 万人 1.12 至 6.96 例,女性发病率更高,随纬度增加三倍,随研究中点年份增加一倍。北部从 20 世纪 60 年代和 70 年代开始呈上升趋势,法罗群岛的历史发病率下降,1980-2000 年期间数据较为稳定;1970-2000 年间,意大利和法国的发病率上升,1980 年代在埃夫罗斯(希腊)上升,2000 年左右在法属西印度群岛上升。

结论

我们得出的结论是,多发性硬化症发病率的增加只是表面现象,而且并非女性特有。对多发性硬化症发病率的监测可能适合欧洲经济区。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/04947eeabc76/1471-2377-13-58-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/d978feaa1543/1471-2377-13-58-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/bcce6dc52bc3/1471-2377-13-58-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/1a9d78bd995e/1471-2377-13-58-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/36a4ca7f3a5d/1471-2377-13-58-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/bdc3488be3a8/1471-2377-13-58-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/04947eeabc76/1471-2377-13-58-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/d978feaa1543/1471-2377-13-58-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/bcce6dc52bc3/1471-2377-13-58-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/1a9d78bd995e/1471-2377-13-58-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/36a4ca7f3a5d/1471-2377-13-58-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/bdc3488be3a8/1471-2377-13-58-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/300a/3686603/04947eeabc76/1471-2377-13-58-6.jpg

相似文献

1
Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.1985-2009 年欧洲经济区人群多发性硬化症发病率:监测框架。
BMC Neurol. 2013 Jun 12;13:58. doi: 10.1186/1471-2377-13-58.
2
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.欧洲多发性硬化症的发病率和患病率:系统评价。
BMC Neurol. 2013 Sep 26;13:128. doi: 10.1186/1471-2377-13-128.
3
Environmental changes and epidemiology of multiple sclerosis in the French West Indies.法属西印度群岛的环境变化与多发性硬化症的流行病学
J Neurol Sci. 2009 Nov 15;286(1-2):58-61. doi: 10.1016/j.jns.2009.04.039. Epub 2009 Jun 10.
4
Multiple Sclerosis Epidemiology in Europe.欧洲的多发性硬化症流行病学
Adv Exp Med Biol. 2017;958:141-159. doi: 10.1007/978-3-319-47861-6_9.
5
Epidemiological data of multiple sclerosis in the province of Evros, Greece.希腊埃夫罗斯省多发性硬化症的流行病学数据。
Eur Neurol. 2003;49(1):8-12. doi: 10.1159/000067020.
6
Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.1990-2010 年英国多发性硬化症的发病率和患病率:一般实践研究数据库中的描述性研究。
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):76-84. doi: 10.1136/jnnp-2013-305450. Epub 2013 Sep 19.
7
Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?德黑兰的多发性硬化症:发病率稳定的同时患病率上升——是真实增长还是诊断水平提高?
Arch Iran Med. 2019 Aug 1;22(8):429-434.
8
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.纬度与多发性硬化症的患病率显著相关:一项荟萃分析。
J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1132-41. doi: 10.1136/jnnp.2011.240432. Epub 2011 Apr 8.
9
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
10
Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands.多发性硬化症:法罗群岛发病时间随时间的变化。
Mult Scler. 2011 Feb;17(2):241-4. doi: 10.1177/1352458510386997. Epub 2010 Oct 26.

引用本文的文献

1
Incidence and Prevalence of Multiple Sclerosis in Malmö, Southern Sweden.瑞典南部马尔默市多发性硬化症的发病率和患病率
Mult Scler Int. 2022 Mar 19;2022:5464370. doi: 10.1155/2022/5464370. eCollection 2022.
2
Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab-A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry.暴露于那他珠单抗的多发性硬化症患者的妊娠结局——来自奥地利多发性硬化症治疗登记处的回顾性分析
Front Neurol. 2020 Aug 4;11:676. doi: 10.3389/fneur.2020.00676. eCollection 2020.
3
Genetic Alterations in Patients with Two Clinical Phenotypes of Multiple Sclerosis.

本文引用的文献

1
Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).多发性硬化症在全国瑞典多发性硬化症登记处(SMSreg)中的性别比例。
Mult Scler. 2013 Jan;19(1):46-52. doi: 10.1177/1352458512446169. Epub 2012 Jun 18.
2
Capture-recapture as a potentially useful procedure for assessing prevalence of multiple sclerosis: methodologic exercise using Portuguese data.捕获再捕获法作为评估多发性硬化症患病率的一种潜在有用的方法:使用葡萄牙数据进行方法学研究。
Neuroepidemiology. 2012;38(4):209-16. doi: 10.1159/000337534. Epub 2012 Apr 27.
3
Genetics of multiple sclerosis: swimming in an ocean of data.
多发性硬化症两种临床表型患者的遗传改变。
J Mol Neurosci. 2020 Jan;70(1):120-130. doi: 10.1007/s12031-019-01408-7. Epub 2019 Nov 4.
4
Dietary Composition and Effects in Inflammatory Bowel Disease.饮食构成与炎症性肠病的影响。
Nutrients. 2019 Jun 21;11(6):1398. doi: 10.3390/nu11061398.
5
Hormonal contraception and the development of autoimmunity: A review of the literature.激素避孕与自身免疫性疾病的发展:文献综述
Linacre Q. 2017 Aug;84(3):275-295. doi: 10.1080/00243639.2017.1360065. Epub 2017 Aug 18.
6
Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.法国多发性硬化症患病率的地理异质性
PLoS One. 2016 Dec 9;11(12):e0167556. doi: 10.1371/journal.pone.0167556. eCollection 2016.
7
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.从泰萨比®(那他珠单抗)妊娠暴露登记处评估妊娠结局:一项全球观察性随访研究。
BMC Neurol. 2016 Aug 24;16(1):150. doi: 10.1186/s12883-016-0674-4.
8
Diet in the pathogenesis and treatment of inflammatory bowel diseases.饮食在炎症性肠病的发病机制及治疗中的作用
Gastroenterology. 2015 May;148(6):1087-106. doi: 10.1053/j.gastro.2015.01.007. Epub 2015 Jan 15.
9
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998-2007.1998 - 2007年葡萄牙里斯本北部多发性硬化症的发病率
BMC Neurol. 2014 Dec 21;14:249. doi: 10.1186/s12883-014-0249-1.
10
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature.治疗依从性及其他患者报告结局作为多发性硬化症成本决定因素的文献综述
Patient Prefer Adherence. 2014 Dec 4;8:1653-64. doi: 10.2147/PPA.S67253. eCollection 2014.
多发性硬化症的遗传学:在数据的海洋中畅游。
Curr Opin Neurol. 2012 Jun;25(3):239-45. doi: 10.1097/WCO.0b013e3283533a93.
4
Response to interferon-Beta treatment in afro-caribbeans with multiple sclerosis.非洲加勒比裔多发性硬化症患者对β-干扰素治疗的反应。
Mult Scler Int. 2011;2011:950126. doi: 10.1155/2011/950126. Epub 2011 May 23.
5
Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.接种大流行流感 A(H1N1)单价佐剂疫苗后出现的神经和自身免疫性疾病:瑞典斯德哥尔摩的基于人群队列研究。
BMJ. 2011 Oct 12;343:d5956. doi: 10.1136/bmj.d5956.
6
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.遗传风险与细胞介导的免疫机制在多发性硬化中的主要作用。
Nature. 2011 Aug 10;476(7359):214-9. doi: 10.1038/nature10251.
7
Epidemiology of multiple sclerosis in south-western Sardinia.撒丁岛西南部多发性硬化症的流行病学研究。
Mult Scler. 2011 Nov;17(11):1282-9. doi: 10.1177/1352458511408754. Epub 2011 Jun 7.
8
Incidence of multiple sclerosis in Iceland, 2002-2007: a population-based study.冰岛多发性硬化症发病率:2002-2007 年基于人群的研究。
Mult Scler. 2011 Aug;17(8):909-13. doi: 10.1177/1352458511402112. Epub 2011 Apr 20.
9
Are the prevalence and incidence of multiple sclerosis changing?多发性硬化症的患病率和发病率正在发生变化吗?
Neuroepidemiology. 2011;36(3):148-9. doi: 10.1159/000325368. Epub 2011 Apr 20.
10
High nationwide prevalence of multiple sclerosis in Sweden.瑞典多发性硬化症的全国高发率。
Mult Scler. 2011 Aug;17(8):901-8. doi: 10.1177/1352458511403794. Epub 2011 Apr 1.